160 related articles for article (PubMed ID: 9536549)
1. Topical glyceryl trinitrate: a possible treatment for cutaneous leishmaniasis.
Zeina B; Banfield C; al-Assad S
Clin Exp Dermatol; 1997 Sep; 22(5):244-5. PubMed ID: 9536549
[TBL] [Abstract][Full Text] [Related]
2. Current treatment for cutaneous leishmaniasis: a review.
Palumbo E
Am J Ther; 2009; 16(2):178-82. PubMed ID: 19300044
[TBL] [Abstract][Full Text] [Related]
3. In-vitro and in-vivo studies on a topical formulation of sitamaquine dihydrochloride for cutaneous leishmaniasis.
Garnier T; Brown MB; Lawrence MJ; Croft SL
J Pharm Pharmacol; 2006 Aug; 58(8):1043-54. PubMed ID: 16872550
[TBL] [Abstract][Full Text] [Related]
4. [Management of cutaneous leishmaniasis in adults and children].
Minodier P; Noël G; Blanc P; Uters M; Retornaz K; Garnier JM
Med Trop (Mars); 2005 Nov; 65(5):487-95. PubMed ID: 16465821
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous leishmaniasis treated with itraconazole.
Baroni A; Aiello FS; Vozza A; Vozza G; Faccenda F; Brasiello M; Ruocco E
Dermatol Ther; 2009 Nov; 22 Suppl 1():S27-9. PubMed ID: 19891689
[TBL] [Abstract][Full Text] [Related]
6. Activity of physalins purified from Physalis angulata in in vitro and in vivo models of cutaneous leishmaniasis.
Guimarães ET; Lima MS; Santos LA; Ribeiro IM; Tomassini TB; Ribeiro dos Santos R; dos Santos WL; Soares MB
J Antimicrob Chemother; 2009 Jul; 64(1):84-7. PubMed ID: 19454526
[TBL] [Abstract][Full Text] [Related]
7. Erythematous-edematous-infiltrative plaque on the face: cutaneous angio-lupoid leishmaniasis.
Guarneri C; Vaccaro M; Cannavò SP; Borgia F; Guarneri B
Eur J Dermatol; 2002; 12(6):597-9. PubMed ID: 12459539
[TBL] [Abstract][Full Text] [Related]
8. Relapse of new world diffuse cutaneous leishmaniasis caused by Leishmania (Leishmania) mexicana after miltefosine treatment.
Calvopina M; Gomez EA; Sindermann H; Cooper PJ; Hashiguchi Y
Am J Trop Med Hyg; 2006 Dec; 75(6):1074-7. PubMed ID: 17172368
[TBL] [Abstract][Full Text] [Related]
9. Serum antioxidant activities, malondialdehyde and nitric oxide levels in human cutaneous leishmaniasis.
Serarslan G; Yilmaz HR; Söğüt S
Clin Exp Dermatol; 2005 May; 30(3):267-71. PubMed ID: 15807687
[TBL] [Abstract][Full Text] [Related]
10. A comparison of glyceryl trinitrate with diclofenac for the treatment of primary dysmenorrhea: an open, randomized, cross-over trial.
Facchinetti F; Sgarbi L; Piccinini F; Volpe A
Gynecol Endocrinol; 2002 Feb; 16(1):39-43. PubMed ID: 11915580
[TBL] [Abstract][Full Text] [Related]
11. [The transcutaneous treatment of superficial thrombophlebitis with the exogenous nitric oxide donor: nitroglycerin].
Berrazueta JR; Ochoteco A; Poveda JJ; Ruiz B; Olalla JJ; Gutiérrez Escalada B; Salas E
Rev Esp Cardiol; 1991; 44(6):424-6. PubMed ID: 1924961
[TBL] [Abstract][Full Text] [Related]
12. Successful topical treatment of murine cutaneous leishmaniasis with a combination of paromomycin (Aminosidine) and gentamicin.
Grogl M; Schuster BG; Ellis WY; Berman JD
J Parasitol; 1999 Apr; 85(2):354-9. PubMed ID: 10219319
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of the intralesional treatment with Chenopodium ambrosioides in the murine infection by Leishmania amazonensis.
Patrício FJ; Costa GC; Pereira PV; Aragão-Filho WC; Sousa SM; Frazão JB; Pereira WS; Maciel MC; Silva LA; Amaral FM; Rebêlo JM; Guerra RN; Ribeiro MN; Nascimento FR
J Ethnopharmacol; 2008 Jan; 115(2):313-9. PubMed ID: 18035510
[TBL] [Abstract][Full Text] [Related]
14. Current diagnosis and treatment of cutaneous and mucocutaneous leishmaniasis.
Goto H; Lindoso JA
Expert Rev Anti Infect Ther; 2010 Apr; 8(4):419-33. PubMed ID: 20377337
[TBL] [Abstract][Full Text] [Related]
15. Tamoxifen as a potential antileishmanial agent: efficacy in the treatment of Leishmania braziliensis and Leishmania chagasi infections.
Miguel DC; Zauli-Nascimento RC; Yokoyama-Yasunaka JK; Katz S; Barbiéri CL; Uliana SR
J Antimicrob Chemother; 2009 Feb; 63(2):365-8. PubMed ID: 19095684
[TBL] [Abstract][Full Text] [Related]
16. Comparing the efficiency of topical paromomycin with intralesional meglumine antimoniate for cutaneous leishmaniasis.
Moosavi Z; Nakhli A; Rassaii S
Int J Dermatol; 2005 Dec; 44(12):1064-5. PubMed ID: 16409282
[No Abstract] [Full Text] [Related]
17. Efficacy of azithromycin versus systemic meglumine antimoniate (Glucantime) in the treatment of cutaneous leishmaniasis.
Layegh P; Yazdanpanah MJ; Vosugh EM; Pezeshkpoor F; Shakeri MT; Moghiman T
Am J Trop Med Hyg; 2007 Jul; 77(1):99-101. PubMed ID: 17620637
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous leishmaniasis: successful treatment with itraconazole.
Consigli J; Danielo C; Gallerano V; Papa M; Guidi A
Int J Dermatol; 2006 Jan; 45(1):46-9. PubMed ID: 16426375
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous leishmaniasis in the returning traveler.
Magill AJ
Infect Dis Clin North Am; 2005 Mar; 19(1):241-66, x-xi. PubMed ID: 15701556
[TBL] [Abstract][Full Text] [Related]
20. Successful liposomal amphotericin B treatment of Leishmania braziliensis cutaneous leishmaniasis.
Brown M; Noursadeghi M; Boyle J; Davidson RN
Br J Dermatol; 2005 Jul; 153(1):203-5. PubMed ID: 16029352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
